Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
 

Posts


Write a Post
04-04-09 08:58 AM
Anonymous
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
Reply
Related Articles

Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.

Eur J Cancer. 2009 Mar 31;

Authors: Liu T, Liu PY, Tee AE, Haber M, Norris MD, Gleave ME, Marshall GM

Histone deacetylase inhibitors (HDACIs) modulate gene transcription and are among the most promising new classes of anticancer drugs. OGX-011, an anti-sense oligonucleotide targeting clusterin, sensitises cancer cells to chemo- and radiotherapies. By reviewing microarray gene profiling data reported in the literature, we identified clusterin as one of only two genes commonly up-regulated by most HDACIs in cancer cell lines of different organ origins. Suppression of clusterin gene expression synergistically enhanced high-dosage HDACI-induced cell death through cytochrome C-mediated mitochondrial apoptosis in HDACI-resistant cancer cells, and synergistically enhanced low-dosage HDACI-induced growth arrest in both HDACI-sensitive and HDACI-resistant tumour cells, but not in normal cells. In mice xenografted with neuroblastoma cells, combination of OGX-011 and the HDACI, valproate, synergistically repressed tumour growth. Our data indicate that HDACI-induced clusterin over-expression renders cancer cells resistant to HDACI-induced growth arrest and apoptosis, and suggests the addition of OGX-011 to HDACIs in future clinical trials in cancer patients.

PMID: 19342222 [PubMed - as supplied by publisher]